about the author

Kyle Blankenship

kyle@endpointsnews.com @ka_blankenship
Kyle Blankenship on LinkedIn

author articles

As­traZeneca's vac­cine hit its first road­block with In­di­an reg­u­la­tors. Will lin­ger­ing doubts de­rail its plans ...

5 years ago
FDA+
Coronavirus

As­traZeneca pub­lish­es in­ter­im vac­cine da­ta in Lancet, re­veals 10 hos­pi­tal­iza­tions, 1 death in piv­otal con­trol arms

5 years ago
FDA+
Coronavirus

Dri­ven by Covid-19 fever, For­bion notes in­vestor in­ter­est in vac­cines and new ther­a­pies as part of $557M fund

5 years ago
Financing
Coronavirus

Amid a record bad year, Bel­licum keeps tak­ing its lumps as FDA slams tri­al hold on CAR-T hope­ful

5 years ago
FDA+
First page Previous page 19202122
A service from the Financial Times